Market Cap 1.75M
Revenue (ttm) 0.00
Net Income (ttm) -10.38M
EPS (ttm) N/A
PE Ratio 0.04
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 173,800
Avg Vol 509,222
Day's Range N/A - N/A
Shares Out 2.05M
Stochastic %K 3%
Beta -0.28
Analysts Strong Sell
Price Target $8.00

Company Profile

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous tramadol, a schedule IV opioid to treat post-operative acute pain. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida.

Industry: Biotechnology
Sector: Healthcare
Phone: 781 652 4500
Address:
1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States
Slippery_Steve
Slippery_Steve Jul. 2 at 7:21 PM
$SNDK $MU $STX $ATXI PUMP AND DUMP ALERT!!!!!!!!!
0 · Reply
PenkeInvesting
PenkeInvesting Jun. 30 at 11:37 AM
Fundamental analysis of $ATXI (AVENUE THERAPEUTICS, INC.) based on financial data and reported results. #ATXI #AVENUE
0 · Reply
chamono1942
chamono1942 Jun. 29 at 4:50 AM
$ATXI $USAR FAQ: When can USAR's new factory start production? According to current plans, production is scheduled to begin in 2028.
0 · Reply
StockBodega
StockBodega May. 14 at 11:12 PM
$ATXI $FBIO Clenbuterol ATX-04 Pompe disease is a rare, inherited lysosomal storage disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA), leading to toxic glycogen buildup, severe muscle weakness, and respiratory/heart issues. It affects approximately 1 in 40,000 people and has infantile-onset (severe) and late-onset forms.Key Aspects of Pompe Disease:Causes: It is an autosomal recessive disorder caused by mutations in the GAA gene, meaning a child must inherit two faulty genes (one from each parent) to develop the disease.
2 · Reply
FinSUN
FinSUN May. 8 at 9:36 AM
$FBIO the stock is still 33% higher YoY. Given the governance, the debt, the unresolved dividends payment and the total disaster of many subsidiaries like $MBIO and $ATXI plus the disappointing revenue of $DERM , not to mention the ongoing dilution with B. $RILY as ATM agent, I consider this still overpriced.
1 · Reply
Gingerbread_man
Gingerbread_man May. 5 at 4:59 PM
$ATXI a hope and a prayer is just not enough for auch claims 😂
0 · Reply
Miguli80
Miguli80 Apr. 25 at 11:28 AM
$ATXI wait this will fly big
0 · Reply
thesaltier1
thesaltier1 Apr. 23 at 5:59 PM
$FBIOP anyone watching what $ATXI is doing, small trades have sent it up 400% in the last few months,
1 · Reply
thesaltier1
thesaltier1 Apr. 23 at 5:57 PM
$ATXI this is so thinly traded if the meme crowd gets ahold of it we could see 10-50X upside
0 · Reply
tradeXLNC
tradeXLNC Apr. 10 at 10:23 PM
Investing $3,000 in $ATXI last year would be worth approx $100,000 today. This is the kind of return I love to see and is always an investors dream. All you need is due diligence. Stop it with the negative mindset and make it happen.
0 · Reply
Latest News on ATXI
No data available.
Slippery_Steve
Slippery_Steve Jul. 2 at 7:21 PM
$SNDK $MU $STX $ATXI PUMP AND DUMP ALERT!!!!!!!!!
0 · Reply
PenkeInvesting
PenkeInvesting Jun. 30 at 11:37 AM
Fundamental analysis of $ATXI (AVENUE THERAPEUTICS, INC.) based on financial data and reported results. #ATXI #AVENUE
0 · Reply
chamono1942
chamono1942 Jun. 29 at 4:50 AM
$ATXI $USAR FAQ: When can USAR's new factory start production? According to current plans, production is scheduled to begin in 2028.
0 · Reply
StockBodega
StockBodega May. 14 at 11:12 PM
$ATXI $FBIO Clenbuterol ATX-04 Pompe disease is a rare, inherited lysosomal storage disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA), leading to toxic glycogen buildup, severe muscle weakness, and respiratory/heart issues. It affects approximately 1 in 40,000 people and has infantile-onset (severe) and late-onset forms.Key Aspects of Pompe Disease:Causes: It is an autosomal recessive disorder caused by mutations in the GAA gene, meaning a child must inherit two faulty genes (one from each parent) to develop the disease.
2 · Reply
FinSUN
FinSUN May. 8 at 9:36 AM
$FBIO the stock is still 33% higher YoY. Given the governance, the debt, the unresolved dividends payment and the total disaster of many subsidiaries like $MBIO and $ATXI plus the disappointing revenue of $DERM , not to mention the ongoing dilution with B. $RILY as ATM agent, I consider this still overpriced.
1 · Reply
Gingerbread_man
Gingerbread_man May. 5 at 4:59 PM
$ATXI a hope and a prayer is just not enough for auch claims 😂
0 · Reply
Miguli80
Miguli80 Apr. 25 at 11:28 AM
$ATXI wait this will fly big
0 · Reply
thesaltier1
thesaltier1 Apr. 23 at 5:59 PM
$FBIOP anyone watching what $ATXI is doing, small trades have sent it up 400% in the last few months,
1 · Reply
thesaltier1
thesaltier1 Apr. 23 at 5:57 PM
$ATXI this is so thinly traded if the meme crowd gets ahold of it we could see 10-50X upside
0 · Reply
tradeXLNC
tradeXLNC Apr. 10 at 10:23 PM
Investing $3,000 in $ATXI last year would be worth approx $100,000 today. This is the kind of return I love to see and is always an investors dream. All you need is due diligence. Stop it with the negative mindset and make it happen.
0 · Reply
StockBodega
StockBodega Apr. 1 at 6:59 PM
$FBIO $FBIOP $ATXI Why is Avenue Therapeutics jumping so hi today? They jump 86% and FBIO is down 5%? Make it make sense nervously 😂
1 · Reply
FinSUN
FinSUN Feb. 2 at 9:03 PM
$ATXI close this farse
0 · Reply
FinSUN
FinSUN Jan. 30 at 6:19 PM
$ATXI massive failure. close this ticket. it's ridicoulous
0 · Reply
Miguli80
Miguli80 Oct. 22 at 10:34 AM
$ATXI sell at 1000$
0 · Reply
Travelling
Travelling Oct. 21 at 1:54 PM
$VSEE Bought to hold. Watching $CLOV $ATXI $MI $GNPX
0 · Reply
FinSUN
FinSUN Sep. 16 at 9:02 PM
0 · Reply
wehavethem62
wehavethem62 Sep. 9 at 7:12 PM
0 · Reply
FinSUN
FinSUN Sep. 9 at 3:44 PM
0 · Reply
FinSUN
FinSUN Sep. 4 at 7:52 PM
0 · Reply
FinSUN
FinSUN Sep. 4 at 3:25 PM
$ATXI forgotten by God... I think something is coming.
1 · Reply